[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fFTT6iCdb6eNT_impkd7LZqKnwhUCrrSlDVB_Q_aNApI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":82,"rows":89},"Region Stockholm",[4],115,false,74,3,3656931,16,102,[14,16,18,20,22,25,27,29],{"name":15,"count":9},"Depression",{"name":17,"count":9},"Heart Failure",{"name":19,"count":9},"Endometriosis",{"name":21,"count":9},"Clubfoot",{"name":23,"count":24},"Vestibular Disorder",2,{"name":26,"count":24},"Psychiatric Inpatients",{"name":28,"count":24},"Intracerebral Hemorrhage",{"name":30,"count":24},"Death",[32,37,42,47,52,57,62,67,72,77],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT06941636","Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders","2026-12-01","5U\u002F0,1 ml Botulinum toxin A",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05810311","The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy","2027-01-01","Roxadustat",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT07617272","Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore","2027-06","Darolutamide",{"nctId":48,"briefTitle":49,"date":50,"intervention":51},"NCT07149662","Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy","2027-10","monoclonal CD-20 antibodies",{"nctId":53,"briefTitle":54,"date":55,"intervention":56},"NCT07187570","RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care","2027-12","Dapagliflozin 10 mg once daily",{"nctId":58,"briefTitle":59,"date":60,"intervention":61},"NCT05679024","Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation","2027-12-31","Apixaban 2.5 milligram Oral",{"nctId":63,"briefTitle":64,"date":65,"intervention":66},"NCT07464730","Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult","2028-03-09","High Flow Oxygen",{"nctId":68,"briefTitle":69,"date":70,"intervention":71},"NCT07305922","Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension","2029-12-31","Induced hypertension with norepinephrine",{"nctId":73,"briefTitle":74,"date":75,"intervention":76},"NCT06051240","Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy","2030-08-31","Lithium",{"nctId":78,"briefTitle":79,"date":80,"intervention":81},"NCT06376279","Genetic Diagnosis in Inborn Errors of Metabolism","2030-12-31","IEM-EP",[83,84,85,86,87,88],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[90,114,142,164,182,206,224,246,274,297,315,342,364,382,407,425,443,469,495],{"intervention":56,"totalTrials":91,"cells":92},1,{"EARLY_PHASE1":93,"PHASE1":96,"PHASE2":98,"PHASE3":100,"PHASE4":110,"NA":112},{"trials":94,"activeCount":95},[],0,{"trials":97,"activeCount":95},[],{"trials":99,"activeCount":95},[],{"trials":101,"activeCount":91,"soonestReadout":55},[102],{"nctId":53,"briefTitle":54,"status":103,"phases":104,"primaryCompletion":55,"completion":55,"start":105,"enrollment":106,"conditions":107,"interventions":109},"RECRUITING",[86],"2025-06-03",1600,[108],"Atrial Fibrillation (AF)",[56],{"trials":111,"activeCount":95},[],{"trials":113,"activeCount":95},[],{"intervention":61,"totalTrials":91,"cells":115},{"EARLY_PHASE1":116,"PHASE1":118,"PHASE2":120,"PHASE3":122,"PHASE4":138,"NA":140},{"trials":117,"activeCount":95},[],{"trials":119,"activeCount":95},[],{"trials":121,"activeCount":95},[],{"trials":123,"activeCount":91,"soonestReadout":60},[124],{"nctId":58,"briefTitle":59,"status":103,"phases":125,"primaryCompletion":60,"completion":126,"start":127,"enrollment":128,"conditions":129,"interventions":137},[86],"2028-12-31","2023-02-17",1400,[130,131,132,28,133,134,30,135,136],"Chronic Kidney Diseases","Atrial Fibrillation","Stroke","Major Bleed","Cardiovascular Complication","Kidney Transplant; Complications","Thromboses, Venous",[61],{"trials":139,"activeCount":95},[],{"trials":141,"activeCount":95},[],{"intervention":36,"totalTrials":91,"cells":143},{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":148,"PHASE3":150,"PHASE4":160,"NA":162},{"trials":145,"activeCount":95},[],{"trials":147,"activeCount":95},[],{"trials":149,"activeCount":95},[],{"trials":151,"activeCount":91,"soonestReadout":35},[152],{"nctId":33,"briefTitle":34,"status":103,"phases":153,"primaryCompletion":35,"completion":35,"start":154,"enrollment":155,"conditions":156,"interventions":158},[86],"2025-05-01",90,[157],"Temporomandibular Disorder",[36,159],"10U\u002F0,1 ml Botulinum toxin A",{"trials":161,"activeCount":95},[],{"trials":163,"activeCount":95},[],{"intervention":159,"totalTrials":91,"cells":165},{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":178,"NA":180},{"trials":167,"activeCount":95},[],{"trials":169,"activeCount":95},[],{"trials":171,"activeCount":95},[],{"trials":173,"activeCount":91,"soonestReadout":35},[174],{"nctId":33,"briefTitle":34,"status":103,"phases":175,"primaryCompletion":35,"completion":35,"start":154,"enrollment":155,"conditions":176,"interventions":177},[86],[157],[36,159],{"trials":179,"activeCount":95},[],{"trials":181,"activeCount":95},[],{"intervention":41,"totalTrials":91,"cells":183},{"EARLY_PHASE1":184,"PHASE1":186,"PHASE2":188,"PHASE3":200,"PHASE4":202,"NA":204},{"trials":185,"activeCount":95},[],{"trials":187,"activeCount":95},[],{"trials":189,"activeCount":91,"soonestReadout":40},[190],{"nctId":38,"briefTitle":39,"status":191,"phases":192,"primaryCompletion":40,"completion":60,"start":193,"enrollment":194,"conditions":195,"interventions":198},"NOT_YET_RECRUITING",[85],"2025-06-01",30,[196,197],"Diabetes Complications","Diabetes; Nephropathy (Manifestation)",[41,199],"Darbepoietin Alfa",{"trials":201,"activeCount":95},[],{"trials":203,"activeCount":95},[],{"trials":205,"activeCount":95},[],{"intervention":199,"totalTrials":91,"cells":207},{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":218,"PHASE4":220,"NA":222},{"trials":209,"activeCount":95},[],{"trials":211,"activeCount":95},[],{"trials":213,"activeCount":91,"soonestReadout":40},[214],{"nctId":38,"briefTitle":39,"status":191,"phases":215,"primaryCompletion":40,"completion":60,"start":193,"enrollment":194,"conditions":216,"interventions":217},[85],[196,197],[41,199],{"trials":219,"activeCount":95},[],{"trials":221,"activeCount":95},[],{"trials":223,"activeCount":95},[],{"intervention":46,"totalTrials":91,"cells":225},{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":240,"PHASE4":242,"NA":244},{"trials":227,"activeCount":95},[],{"trials":229,"activeCount":95},[],{"trials":231,"activeCount":91,"soonestReadout":45},[232],{"nctId":43,"briefTitle":44,"status":103,"phases":233,"primaryCompletion":45,"completion":234,"start":235,"enrollment":236,"conditions":237,"interventions":239},[85],"2030-12","2025-11-09",100,[238],"Prostate Cancer (Adenocarcinoma)",[46],{"trials":241,"activeCount":95},[],{"trials":243,"activeCount":95},[],{"trials":245,"activeCount":95},[],{"intervention":76,"totalTrials":91,"cells":247},{"EARLY_PHASE1":248,"PHASE1":250,"PHASE2":252,"PHASE3":268,"PHASE4":270,"NA":272},{"trials":249,"activeCount":95},[],{"trials":251,"activeCount":95},[],{"trials":253,"activeCount":91,"soonestReadout":75},[254],{"nctId":73,"briefTitle":74,"status":103,"phases":255,"primaryCompletion":75,"completion":256,"start":257,"enrollment":258,"conditions":259,"interventions":267},[85],"2033-08-31","2024-02-16",84,[260,261,262,263,264,265,266],"Cognitive Impairment","Cognitive Decline","Radiotherapy Side Effect","Radiotherapy; Complications","Brain Tumor","Memory Impairment","Late Effect of Radiation",[76],{"trials":269,"activeCount":95},[],{"trials":271,"activeCount":95},[],{"trials":273,"activeCount":95},[],{"intervention":66,"totalTrials":91,"cells":275},{"EARLY_PHASE1":276,"PHASE1":278,"PHASE2":280,"PHASE3":282,"PHASE4":284,"NA":286},{"trials":277,"activeCount":95},[],{"trials":279,"activeCount":95},[],{"trials":281,"activeCount":95},[],{"trials":283,"activeCount":95},[],{"trials":285,"activeCount":95},[],{"trials":287,"activeCount":91,"soonestReadout":65},[288],{"nctId":63,"briefTitle":64,"status":103,"phases":289,"primaryCompletion":65,"completion":290,"start":291,"enrollment":292,"conditions":293,"interventions":295},[88],"2029-03-09","2026-04-20",200,[294],"Postoperative Pulmonary Complications (PPCs)",[66,296],"Oxygen",{"intervention":296,"totalTrials":91,"cells":298},{"EARLY_PHASE1":299,"PHASE1":301,"PHASE2":303,"PHASE3":305,"PHASE4":307,"NA":309},{"trials":300,"activeCount":95},[],{"trials":302,"activeCount":95},[],{"trials":304,"activeCount":95},[],{"trials":306,"activeCount":95},[],{"trials":308,"activeCount":95},[],{"trials":310,"activeCount":91,"soonestReadout":65},[311],{"nctId":63,"briefTitle":64,"status":103,"phases":312,"primaryCompletion":65,"completion":290,"start":291,"enrollment":292,"conditions":313,"interventions":314},[88],[294],[66,296],{"intervention":81,"totalTrials":91,"cells":316},{"EARLY_PHASE1":317,"PHASE1":319,"PHASE2":321,"PHASE3":323,"PHASE4":325,"NA":327},{"trials":318,"activeCount":95},[],{"trials":320,"activeCount":95},[],{"trials":322,"activeCount":95},[],{"trials":324,"activeCount":95},[],{"trials":326,"activeCount":95},[],{"trials":328,"activeCount":91,"soonestReadout":80},[329],{"nctId":78,"briefTitle":79,"status":330,"phases":331,"primaryCompletion":80,"completion":80,"start":332,"enrollment":333,"conditions":334,"interventions":341},"ENROLLING_BY_INVITATION",[],"2008-04-29",1000,[335,336,337,338,339,340],"Metabolic Disease","Mitochondrial Diseases","Epilepsy in Children","Epilepsy","LHON","Motor Neuron Disease",[81],{"intervention":71,"totalTrials":91,"cells":343},{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":350,"PHASE4":352,"NA":354},{"trials":345,"activeCount":95},[],{"trials":347,"activeCount":95},[],{"trials":349,"activeCount":95},[],{"trials":351,"activeCount":95},[],{"trials":353,"activeCount":95},[],{"trials":355,"activeCount":91,"soonestReadout":70},[356],{"nctId":68,"briefTitle":69,"status":103,"phases":357,"primaryCompletion":70,"completion":80,"start":358,"enrollment":292,"conditions":359,"interventions":362},[],"2025-12-01",[360,361],"Subarachnoid Aneurysm Hemorrhage","Cerebral Vasospasm After Subarachnoid Hemorrhage",[71,363],"Endoluminal Spasmolysis",{"intervention":363,"totalTrials":91,"cells":365},{"EARLY_PHASE1":366,"PHASE1":368,"PHASE2":370,"PHASE3":372,"PHASE4":374,"NA":376},{"trials":367,"activeCount":95},[],{"trials":369,"activeCount":95},[],{"trials":371,"activeCount":95},[],{"trials":373,"activeCount":95},[],{"trials":375,"activeCount":95},[],{"trials":377,"activeCount":91,"soonestReadout":70},[378],{"nctId":68,"briefTitle":69,"status":103,"phases":379,"primaryCompletion":70,"completion":80,"start":358,"enrollment":292,"conditions":380,"interventions":381},[],[360,361],[71,363],{"intervention":51,"totalTrials":91,"cells":383},{"EARLY_PHASE1":384,"PHASE1":386,"PHASE2":388,"PHASE3":390,"PHASE4":392,"NA":394},{"trials":385,"activeCount":95},[],{"trials":387,"activeCount":95},[],{"trials":389,"activeCount":95},[],{"trials":391,"activeCount":95},[],{"trials":393,"activeCount":95},[],{"trials":395,"activeCount":91,"soonestReadout":50},[396],{"nctId":48,"briefTitle":49,"status":191,"phases":397,"primaryCompletion":50,"completion":398,"start":399,"enrollment":400,"conditions":401,"interventions":404},[],"2028-03","2026-02",111,[402,403],"Multiple Sclerosis","Pregnancy",[51,405,406],"No Drug","Other treatment",{"intervention":405,"totalTrials":91,"cells":408},{"EARLY_PHASE1":409,"PHASE1":411,"PHASE2":413,"PHASE3":415,"PHASE4":417,"NA":419},{"trials":410,"activeCount":95},[],{"trials":412,"activeCount":95},[],{"trials":414,"activeCount":95},[],{"trials":416,"activeCount":95},[],{"trials":418,"activeCount":95},[],{"trials":420,"activeCount":91,"soonestReadout":50},[421],{"nctId":48,"briefTitle":49,"status":191,"phases":422,"primaryCompletion":50,"completion":398,"start":399,"enrollment":400,"conditions":423,"interventions":424},[],[402,403],[51,405,406],{"intervention":406,"totalTrials":91,"cells":426},{"EARLY_PHASE1":427,"PHASE1":429,"PHASE2":431,"PHASE3":433,"PHASE4":435,"NA":437},{"trials":428,"activeCount":95},[],{"trials":430,"activeCount":95},[],{"trials":432,"activeCount":95},[],{"trials":434,"activeCount":95},[],{"trials":436,"activeCount":95},[],{"trials":438,"activeCount":91,"soonestReadout":50},[439],{"nctId":48,"briefTitle":49,"status":191,"phases":440,"primaryCompletion":50,"completion":398,"start":399,"enrollment":400,"conditions":441,"interventions":442},[],[402,403],[51,405,406],{"intervention":444,"totalTrials":91,"cells":445},"Cholecalciferol",{"EARLY_PHASE1":446,"PHASE1":448,"PHASE2":450,"PHASE3":463,"PHASE4":465,"NA":467},{"trials":447,"activeCount":95},[],{"trials":449,"activeCount":95},[],{"trials":451,"activeCount":95},[452],{"nctId":453,"briefTitle":454,"status":455,"phases":456,"primaryCompletion":457,"completion":457,"start":458,"enrollment":459,"conditions":460,"interventions":462},"NCT03038516","'Palliative-D' Vitamin D to Palliative Cancer Patients","COMPLETED",[85],"2020-06-09","2017-11-01",244,[461],"Vitamin D Deficiency",[444],{"trials":464,"activeCount":95},[],{"trials":466,"activeCount":95},[],{"trials":468,"activeCount":95},[],{"intervention":470,"totalTrials":91,"cells":471},"Evolocumab",{"EARLY_PHASE1":472,"PHASE1":485,"PHASE2":487,"PHASE3":489,"PHASE4":491,"NA":493},{"trials":473,"activeCount":95},[474],{"nctId":475,"briefTitle":476,"status":477,"phases":478,"primaryCompletion":479,"completion":479,"start":480,"enrollment":481,"conditions":482,"interventions":484},"NCT06140095","Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism","UNKNOWN",[83],"2025-12","2024-02",8,[483],"Acute Metabolic Effects of Evolocumab and Atorvastatin",[470],{"trials":486,"activeCount":95},[],{"trials":488,"activeCount":95},[],{"trials":490,"activeCount":95},[],{"trials":492,"activeCount":95},[],{"trials":494,"activeCount":95},[],{"intervention":496,"totalTrials":91,"cells":497},"Anti-CD20 Monoclonal Antibody",{"EARLY_PHASE1":498,"PHASE1":500,"PHASE2":502,"PHASE3":504,"PHASE4":506,"NA":508},{"trials":499,"activeCount":95},[],{"trials":501,"activeCount":95},[],{"trials":503,"activeCount":95},[],{"trials":505,"activeCount":95},[],{"trials":507,"activeCount":95},[],{"trials":509,"activeCount":95},[510],{"nctId":511,"briefTitle":512,"status":477,"phases":513,"primaryCompletion":479,"completion":479,"start":514,"enrollment":400,"conditions":515,"interventions":520},"NCT06711354","B-cell Depletion in Offspring to Women With MS Under Immunomodulatory Treatment",[],"2025-06",[402,516,517,518,519],"B-Cell Deficiency","Offspring, Adult","Immunosuppression","Pregnancy Related",[496]]